| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.095 | 0.06 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.21 | 0.06 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |